1. Azithromycin: risk of fatal heart-rhythm disorders

   News item 25 November 2023 Pages: 1 - 1

2. BioCeuticals zinc drops recalled in Australia

   Media release 25 November 2023 Pages: 2 - 2

3. Meningococcal vaccine Nimenrix: risk of allergic reaction

   News item 25 November 2023 Pages: 3 - 3

4. Revisions of precautions for preparations containing acetaminophen in Japan

   News item 25 November 2023 Pages: 4 - 4

5. Side effects of medications in transgender people

   News item 25 November 2023 Pages: 5 - 5

6. Voluntary recall of various eye drops for potential safety reason

   Media release 25 November 2023 Pages: 6 - 6

7. Combined hormonal contraceptives: 2−4 weeks' cessation eliminates thrombotic risk

   Clinical study 25 November 2023 Pages: 7 - 7

8. Lower risk of gastrointestinal dysfunction with atypical vs typical antipsychotics

   Clinical study 25 November 2023 Pages: 8 - 8

9. Pertuzumab-associated AEs: disproportionality analysis of FAERS data

   Clinical study 25 November 2023 Pages: 9 - 9

10. Standard- vs reduced-dose DOAC for older adults: greater risk of bleeding with standard dose

    Clinical study 25 November 2023 Pages: 10 - 10

11. Vitamin D insufficiency risk factor for paclitaxel-induced peripheral neuropathy

    Clinical study 25 November 2023 Pages: 11 - 11

12. Zoledronic acid for osteoporosis: risk of renal impairment

    Clinical study 25 November 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 25 November 2023 Pages: 13 - 13

14. β-adrenergic receptor agonists/Corticosteroids/Omalizumab

    Case report 25 November 2023 Pages: 14 - 14

15. Abaloparatide

    Case report 25 November 2023 Pages: 15 - 15

16. Abatacept/doxycycline/methotrexate

    Case report 25 November 2023 Pages: 16 - 16

17. Abemaciclib/fulvestrant

    Case report 25 November 2023 Pages: 17 - 17

18. Adagrasib

    Case report 25 November 2023 Pages: 18 - 18

19. Adalimumab

    Case report 25 November 2023 Pages: 19 - 19

20. Adalimumab

    Case report 25 November 2023 Pages: 20 - 20

21. Adalimumab/zoledronic-acid

    Case report 25 November 2023 Pages: 21 - 21

22. Alcohol

    Case report 25 November 2023 Pages: 22 - 22

23. Alemtuzumab

    Case report 25 November 2023 Pages: 23 - 23

24. Alemtuzumab

    Case report 25 November 2023 Pages: 24 - 24

25. Alemtuzumab

    Case report 25 November 2023 Pages: 25 - 25

26. Alemtuzumab

    Case report 25 November 2023 Pages: 26 - 26

27. Alemtuzumab

    Case report 25 November 2023 Pages: 27 - 27

28. Alendronic-acid

    Case report 25 November 2023 Pages: 28 - 28

29. Alpelisib

    Case report 25 November 2023 Pages: 29 - 29

30. Alpelisib

    Case report 25 November 2023 Pages: 30 - 30

31. Alpelisib

    Case report 25 November 2023 Pages: 31 - 31

32. Alpelisib

    Case report 25 November 2023 Pages: 32 - 32

33. Alpelisib

    Case report 25 November 2023 Pages: 33 - 33

34. Alpelisib

    Case report 25 November 2023 Pages: 34 - 34

35. Alpelisib

    Case report 25 November 2023 Pages: 35 - 35

36. Alpelisib

    Case report 25 November 2023 Pages: 36 - 36

37. Alpelisib/Metformin

    Case report 25 November 2023 Pages: 37 - 37

38. Alpelisib/metformin/paclitaxel

    Case report 25 November 2023 Pages: 38 - 38

39. Alteplase/heparin

    Case report 25 November 2023 Pages: 39 - 39

40. Amantadine/Insulin-glargine/Insulin-lispro

    Case report 25 November 2023 Pages: 40 - 40

41. Amikacin-sulfate

    Case report 25 November 2023 Pages: 41 - 41

42. Amikacin/capreomycin/kanamycin

    Case report 25 November 2023 Pages: 42 - 42

43. Amiodarone

    Case report 25 November 2023 Pages: 43 - 43

44. Amiodarone

    Case report 25 November 2023 Pages: 44 - 44

45. Amiodarone/Thiamazole

    Case report 25 November 2023 Pages: 45 - 45

46. Amoxicillin/clavulanic-acid/ibuprofen

    Case report 25 November 2023 Pages: 46 - 46

47. Amphotericin-b-liposomal

    Case report 25 November 2023 Pages: 47 - 47

48. Amphotericin-b-liposomal/flucytosine/methylprednisolone

    Case report 25 November 2023 Pages: 48 - 48

49. Anakinra/Aspirin/Immune-globulin/Methylprednisolone

    Case report 25 November 2023 Pages: 49 - 49

50. Anakinra/Methotrexate/Prednisone

    Case report 25 November 2023 Pages: 50 - 50